BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B

Compounds That Target HCK

HCK proto-oncogene, Src family tyrosine kinase · 56 compounds in BiohacksAI corpus

HCK (HCK proto-oncogene, Src family tyrosine kinase) is a biological target with 56 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into HCK modulation for therapeutic and biohacking applications.

All 50 Compounds — Ranked by Evidence
1
Gefitinib
5.67
confidence
2
Erlotinib
5.55
confidence
3
Ibrutinib
4.86
confidence
4
Cabozantinib
4.39
confidence
5
Foretinib
4.34
confidence
6
Tozasertib
4.33
confidence
7
Vandetanib
4.30
confidence
8
Ponatinib
4.26
confidence
9
Nilotinib
4.17
confidence
10
Bosutinib
4.08
confidence
11
Doramapimod
4.06
confidence
12
Midostaurin
3.85
confidence
13
Brigatinib
3.81
confidence
14
Pazopanib
3.69
confidence
15
Neratinib
3.66
confidence
16
Nintedanib
3.61
confidence
17
Canertinib
3.53
confidence
18
Pelitinib
3.50
confidence
19
Tae 684
3.43
confidence
20
Fedratinib
3.40
confidence
21
Gilteritinib
3.40
confidence
22
Mln 8054
3.33
confidence
23
Saracatinib
3.33
confidence
24
Dabrafenib
3.30
confidence
25
Neflamapimod
3.30
confidence
26
Alisertib
3.30
confidence
27
Dovitinib
3.09
confidence
28
At 9283
3.09
confidence
29
Dasatinib Anhydrous
3.09
confidence
30
Lestaurtinib
3.04
confidence
31
Ruboxistaurin
2.94
confidence
32
Danusertib
2.94
confidence
33
Defosbarasertib
2.89
confidence
34
Barasertib
2.89
confidence
35
R 406
2.83
confidence
36
Cediranib
2.83
confidence
37
Milciclib
2.77
confidence
38
Masitinib
2.77
confidence
39
Plx 4720
2.71
confidence
40
Kw 2449
2.64
confidence
41
Ast 487
2.56
confidence
42
Raf 265
2.48
confidence
43
Motesanib
2.48
confidence
44
Brivanib
2.48
confidence
45
Azd 7762
2.30
confidence
46
Su 014813
2.20
confidence
47
Rebastinib
2.20
confidence
48
Golvatinib
2.20
confidence
49
Cyc 116
2.08
confidence
50
Asp 3026
2.08
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for HCK (HCK proto-oncogene, Src family tyrosine kinase). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: HCK target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.